EcoDrugPlus

Ensembl ID : ML01926a
Gene Symbol: -
External references: -
172 Possible Orthologues:

Ensembl ID : ML01927a
Gene Symbol: -
External references: -
172 Possible Orthologues:

Ensembl ID : ML01928a
Gene Symbol: -
External references: -
172 Possible Orthologues:

Ensembl ID : ML02112a
Gene Symbol: -
External references: -
74 Possible Orthologues:

Ensembl ID : ML021138a
Gene Symbol: -
External references: -
73 Possible Orthologues:

Ensembl ID : ML02162a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML02197a
Gene Symbol: -
External references: -
333 Possible Orthologues:

Ensembl ID : ML02231a
Gene Symbol: -
External references: -
193 Possible Orthologues:

Ensembl ID : ML023017a
Gene Symbol: -
External references: -
129 Possible Orthologues:

Ensembl ID : ML02306a
Gene Symbol: -
External references: -
126 Possible Orthologues:

Ensembl ID : ML02335a
Gene Symbol: -
External references: -
93 Possible Orthologues:

Ensembl ID : ML050915a
Gene Symbol: -
External references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).